Tanpreet Kaur, PhD

Dr. Tanpreet Kaur obtained a PhD (organic chemistry, Prof. K. N. Ganesh) from National Chemical Laboratory (Pune), India in 2013. This was followed by postdoctoral research at Indian Institute of Technology, Roorkee (2014-2016). Afterwards, she was a postdoctoral fellow at the University of Michigan from 2016-2021.

Dr. Tanpreet Kaur has earned numerous prestigious awards and fellowships over the course of her career. Among these accolades, two particularly noteworthy honors stand out: the Post-Doctoral Fellowship at the Indian Institute of Technology, India, spanning from 2014 to 2016, and the DST-DFG fellowship for Lindau's Nobel Laureates Meetings in Germany in 2009. In addition to these notable distinctions, Dr. Kaur has garnered recognition through various other accolades, including the National Junior Research Fellowship (JRF) and several prestigious gold medals from Lucknow University in 2003. Furthermore, her recent attainment of the First Place Young Investigator Award at the Society of Nuclear Medicine and Molecular Imaging Conference in 2023 serves as a testament to her outstanding accomplishments and leadership within her field.

Her contributions in the field of radiochemistry included the synthesis and testing of radiotracers for PET studies, such as the selective delta-opioid receptor (DOR) antagonist ¹¹C-MeNTI and kappa-opioid receptor antagonist ¹¹C-LY2795050, as well as the development of a selective ¹⁸F-labelled radiotracer for Huntington's disease. She supported CMC section of the IND filing of radiotracer 11C-COU for MAO-B PET studies.

Dr. Kaur is the co-author of 34 peer-reviewed publications covering various aspects of radiochemistry, including the development of innovative strategies for the synthesis of radiotracers for targeting receptors or biological processes, co-author of 12 conference abstracts and a patent.